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MaOBJECTIVES The aim of this study was to assess factors inﬂuencing the clinical outcome and morphological changes of
acute and chronic type B aortic dissection after thoracic endovascular aortic repair (TEVAR).
BACKGROUND Aortic remodeling after TEVAR may be associated with clinical outcome, complications, and endoleak
development.
METHODS Sixty cases of TEVAR for complicated type B acute aortic dissection (AAD) (n ¼ 29) and chronic aortic
dissection (CAD) (n ¼ 31) with a minimum follow-up of 3 years were retrospectively reviewed. Using computed
tomography images, we assessed true lumen, false lumen, and total aortic short-axis diameters. Six procedural factors
were analyzed in relation to aortic remodeling and other outcomes. Analysis of variance was used to compare short-axis,
false lumen, and true lumen diameters during the follow-up period. Univariate and multivariate analyses were used to
assess the relationship between procedural factors and multiple outcomes.
RESULTS A total of 100 stent grafts were implanted in 60 consecutive patients with acute aortic dissection (AAD) and
CAD. Aortic remodeling consisting of false lumen thrombosis and shrinkage was more prominent in AAD than in CAD,
especially within the ﬁrst 18 months. Of note, the entire aortic diameter increased signiﬁcantly cephalad to the stent graft
in AAD. Only in the AAD group there was increased aortic remodeling related to post-dilation of the stent graft. Type I
and II endoleaks occurred in 17 patients (28%); in AAD, embolization of the left subclavian artery after stent graft
deployment was signiﬁcantly associated with a lower risk of endoleak development, but this was not evident in CAD.
CONCLUSIONS Aortic remodeling and clinical outcome after TEVAR can be inﬂuenced by procedural techniques
(post-dilation and embolization of the left subclavian artery in patients with acute but not chronic aortic dissection).
(J Am Coll Cardiol Intv 2016;9:183–91) © 2016 by the American College of Cardiology Foundation.T horacic endovascular aortic repair (TEVAR) isan effective treatment for complicated type Baortic dissection in either the acute or
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ABBR EV I A T I ON S
AND ACRONYMS
AAD = acute aortic dissection
CAD = chronic aortic dissection
CTA = computed tomography
angiography
FL = false lumen
LSA = left subclavian artery
MAE = major adverse event(s)
TEVAR = thoracic
endovascular aortic repair
TL = true lumen
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184enlargement of the true lumen (TL) without
enlargement of the total aortic diameter.
A higher survival rate has been reported in
those patients who achieved aortic remodel-
ing (5-mm reduction in the maximal
descending thoracic aortic diameter) from
pre-operative imaging to ﬁnal follow-up (1,5).SEE PAGE 192The efﬁcacy of TEVAR in facilitating aortic
remodeling was highlighted recently by the
INSTEAD-XL (Investigation of Stent-grafts in
Aortic Dissection) trial. In this study, TEVARin uncomplicated dissection produced aortic remod-
eling and reduced aorta-related mortality compared
with medical therapy (2). A new frontier in the endo-
vascular treatment of thoracic aortic dissection is to
explore the morphological changes that occur in the
stented segment and in the adjacent aorta when fol-
lowed over a long-term follow-up period. It has been
suggested that acute aortic dissections (AADs) show a
higher degree of remodeling compared with chronic
aortic dissections (CADs); however, certain procedural
factors that may affect further clinical outcome,
morphological changes, and endoleaks have not been
fully explored (1–6).
Our study aimed to retrospectively evaluate the
procedural factors that may affect morphological
changes of type B AAD and CAD after TEVAR as well
as endoleak development and clinical outcome.
METHODS
A retrospective study analysis was performed in 60
consecutive patients (age, 69  3.5 years; male/
female, 40/20) who underwent endovascular treat-
ment for acute and chronic Stanford type B aortic
dissection from November 2009 to January 2011.
Dissections were classiﬁed according to the
American College of Cardiology/American Heart
Association guidelines and of the Expert Consensus
of the Society of Thoracic Surgeons Endovascular
Surgery Task Force: acute was deﬁned as #14 days
from the onset of symptoms; chronic dissection (CAD)
was deﬁned by an elapsed time $14 days from
symptom onset (2,4).
Indications for TEVAR in patients with AAD were
aortic rupture (hemothorax, hemomediastinum),
malperfusion syndrome (acute limb ischemia, bowel
ischemia, renal ischemia), persistent pain for >3 days
or hypertension refractory to medical treatment.
Chronic dissections were considered for interven-
tion in the presence of complications as impending
rupture and organ ischemia or unstable bloodpressure, maximal short-axis thoracic aortic diameter
>55 mm, or rapid growth (10 mm/year) of the thoracic
aorta. Patients with underlying inherited (e.g., Mar-
fan syndrome) and inﬂammatory disease (e.g.,
Takayasu syndrome) were not included in the study.
All patients who presented with acute onset of
symptoms (<14 days) not responding to medical
therapy were treated within a few days (1 to 6 days)
from admission. If an acute patient is stable with no
complications, we wait 14 days to decide whether
TEVAR is indicated.
Each patient was informed of the intended treat-
ment and possible complications, and written con-
sent was obtained before the procedure.
The study was approved by the local ethics com-
mittee and the internal review board.
Before the procedure and during the follow-up
(5 days and 6, 12, 24, and 36 months), all patients
were evaluated with clinical assessment and com-
puted tomography angiography (CTA). In case of
anomalous ﬁndings, digital subtraction angiography
was performed.
Clinical success was deﬁned when pre-operative
pathological condition and symptoms (i.e., malper-
fusion syndrome) were resolved by TEVAR.
Using CTA in the true axial plane, we evaluated the
short-axis diameter of the whole aorta, the TL and TL
at 7 different levels: 3 cm and 1 cm above the stent
graft, superior edge of the stent graft, midlevel of the
stent graft, inferior edge of the stent graft, and 1 cm
and 3 cm below the stent graft.
The aortic changes regarding the morphology
and diameter of the TL and FL were assessed and
compared with the pre-treatment CTA ﬁndings.
Univariate and multivariate analyses were used to
assess the following factors that have been associated
with endoleaks and major adverse events (MAE)
(deﬁned as mortality, lack of clinical success, and
major complications): stent graft oversizing; balloon
dilation after stent graft deployment; number of stent
grafts implanted; length of covered thoracic aorta;
covering of the left subclavian artery (LSA); and
embolization of the LSA. All these procedural details
were analyzed and correlated with the presence of
aortic remodeling, endoleaks, or MAE.
STATISTICAL ANALYSIS. A statistical analysis was
done using SPSS version 14.0 (SPSS Inc., Chicago,
Illinois) and Excel for Mac 2008. Continuous variables
were presented as mean with 95% conﬁdence in-
tervals. Comparison of continuous variables was
made by the Student t test. Procedural factors asso-
ciated with absence of aortic remodeling, occurring
endoleaks, or complications were explored using a
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185Cox proportional hazards model. Factors being found
statistically signiﬁcant (p < 0.05) in the univariate
analysis were included in the multivariate analysis.
Results are represented as hazard ratios and 95%
conﬁdence intervals. Hierarchical analysis was per-
formed for the number of stent grafts because in some
patients more than 1 stent graft was implanted.
Categorical variables were analyzed by the chi-
square and Fisher exact tests. Analysis of variance
was used to compare short axis, FL, and TL diameters
over the follow-up period. Regression analysis was
also used to analyze the FL thrombosis in relation to
the lack of MAE and endoleaks. Signiﬁcance was
assumed at p < 0.05.
RESULTS
Patient cardiovascular risk factors and clinical pre-
sentation are presented in Table 1. Twenty-nine pa-
tients (48.3%) were included in the AAD group, and 31
patients (51.7%) in the CAD group.
Clinical success was obtained in 27 patients with
AAD (93.1%) and in all patients with CAD. In 2 pa-
tients with AAD, malperfusion syndrome was not
immediately resolved after the ﬁrst TEVAR, and
therefore an additional stent graft has to be deployed
to resolve the malperfusion syndrome within 7 days.
Clinical outcomes are reported in Table 2. Technical
success was achieved in all patients with correct
deployment of the stent grafts and complete exclu-
sion of the primary entry tear.
Different commercially available stent grafts
were used: Thoracic Excluder Graft (W.L. Gore &TABLE 1 Clinical Features of AADs and CADs Included in
the Study
Clinical Features AADs CADs p Value
Age, yrs 68  5.5 71  3.5 0.7
Male/female 21/11 19/9 0.9
Hypertension 18 (62) 27 (87) 0.03
Diabetes 9 (31) 10 (32) 0.1
Obesity 6 (20) 6 (19) 0.1
Ischemic heart disease 5 (26) 4 (12) 0.1
Peripheral vascular disease 4 (13) 7 (22) 0.1
Smoking 2 (6.8) 6 (19) 0.03
Drug/alcohol abuse 2 (6.8) 1 (3) 0.07
Clinical presentation
Signs of aortic rupture 5 (17) 0 (0) 0.01
Malperfusion syndrome 17 (58.6) 3 (9.6) 0.01
Impaired blood pressure 7 (24.1) 17 (54.8) 0.01
Aortic diameter ($55 mm) 0 (0) 4 (12.9) 0.04
Rapid growth ($10 mm/yr) 0 (0) 7 (22.5) <0.01
Values are mean  SD, n, or n (%).
AADs ¼ acute aortic dissections; CADs ¼ chronic aortic dissections.Associates, Flagstaff, Arizona) (n ¼ 57); Talent LPS
(Medtronic, Minneapolis, Minneapolis) (n ¼ 22);
Valiant-Captivia (Medtronic) (n ¼ 13); Zenith TX (Cook
Medical, Inc., Bloomington, Indiana) (n ¼ 6), Relay
(Bolton Medical Inc., Sunrise, Florida) (n ¼ 2).
The total number of implanted stent grafts was
100: 43 in the AAD group and 57 in the CAD group.
Mean number of stent grafts per patient in the AAD
group was 1.5  0.5 and 1.9  0.8 in the CAD group
(AAD vs. CAD; p ¼ 0.01).
A summary of the technical features of all pro-
cedures is given in Table 3. In theAADgroup, the caliber
of the proximal implanted stent graft ranged from
28mm to 40mm (mean, 344.4mm), while the length
ranged between 10 and 20 cm (mean, 15  4.3 cm).
In the CAD group, the stent graft diameters ranged
from 31 to 47 mm (mean, 39  5.8 mm) with a length
ranging between 10 and 40 cm (mean, 25  11 cm).
The mean proximal neck diameter was 30.8  4.4 mm
in AAD patients and 32.5  3.1 mm in CAD patients
(p ¼ 0.04).
Stent graft oversizing (mean value) in both groups
ranged between 6% and 24% (mean, of 14.9  6.3%),
13.8%  3.5% in the AAD group and 15.5  3.3% in the
CAD group, with no signiﬁcant statistical difference
between the 2 groups (p ¼ 0.31). The degree of stent
graft oversizing was less in those patients in whom a
proximal endoleak subsequently developed (type Ia)
during the follow-up (mean, 4.3  1.7 mm) than in
those patients who did not (mean, 5.3  2.2 mm).
However, ﬁnal values were not signiﬁcantly different
from a statistical point of view in the 2 groups
(p ¼ 0.09).
Univariate and multivariate analyses conﬁrmed
that stent graft oversizing in both AAD and CAD did
not inﬂuence aortic remodeling, endoleak, or MAE
(Tables 4 and 5). The proximal and distal stent graft
diameters were, respectively, 32.5  1.7 mm andTABLE 2 Comparative Evaluation of the Outcomes Post-TEVAR in Patients With
AAD and CAD
Outcome AAD (n ¼ 29) CAD (n ¼ 31) p Value
Major adverse events 10 (34.4) 4 (12.9) 0.05
Lack of clinical success 2 (6.9) 0 (0) 0.35
Mortality, 36 months 4 (13.7) 2 (6.4) 0.35
Endoleak 8 (14) 5 (17) 0.28
Major complications 4 (14) (1 pseudoaneurysm
of the left axillary artery;
2 retrograde extensions of
the dissection; 1 temporary
paraparesis)
2 (3) (1 thoracic aortic
aneurysm formation;
1 dissection of the
left external iliac artery)
0.35
Values are n (%).
TEVAR ¼ thoracic endovascular aortic repair; other abbreviations as in Table 1.
TABLE 3 Technical Data for All Procedures in Patients With AAD and CAD
Procedural Data AAD CAD p Value
Stent grafts 43 57 0.048
Distance of aorta covered, mm 174  18 198  20 0.02
Intentional coverage of the LSA 14 (48) 19 (61) 0.23
Intentional LSA embolization after
stent graft deployment
6 (20.6) 5 (16.1) 0.9
Stent graft dilation 18 (62) 18 (58) 0.1
Mean oversizing, mm 4.5  2.0 (13.8) 6.8  2.1 (15.5) 0.07
Values are n, mean  SD, n (%), or mean  SD (%).
LSA ¼ left subclavian artery; other abbreviations as in Table 1.
TABLE 4 Univariate
Improved Remodeling
Factors
Stent graft oversizing
Balloon dilation after st
No. of stent grafts imp
Length of aorta covere
Covering of the LSA
Embolization of the LS
*Hierarchical analysis.
CI ¼ conﬁdence interval
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18626.9  1.2 mm in AAD and 33.9  1.3 mm and 29.7 
2.0 mm in CAD.
The mean length of the covered thoracic aorta was
174  18 mm in cases of AAD and 198  20 mm in cases
of CAD.
To obtain the complete exclusion of the FL, an
additional stent graft was necessary in 12 cases of
AAD (41%) and in 16 cases of CAD (51%), all of them
were DeBakey type IIIb with the dissection extending
into the abdominal aorta. The overlapping segment
between the 2 stent grafts was at least 5 cm (range,
5.0 to 8.3 cm; mean, 6.6 cm).
The distal landing zone of the stent grafts was be-
tween the T5 and L1 vertebral bodies. Univariate
analysis showed that neither the number of stent
grafts implanted nor the length of aorta covered had
any signiﬁcant relationship with improved FL
thrombosis, endoleaks, or MAE in both AAD and CAD
(Tables 4 and 5).
To reduce the risk of paraplegia in those patients
(n ¼ 20) whose thoracic descending aorta was totally
covered by the stent graft, cerebral spinal ﬂuid pres-
sure was monitored by the insertion of a lumbar
catheter before intervention.
The endovascular treatment of AAD resulted in a
signiﬁcant increase in TL diameter over time (from a
mean of 20.4 mm calculated from all indicated aortaand Multivariate Analysis of Procedural Factors in Relation to
and Complications in AADs (Endoleak, Mortality, and Others)
Univariate Multivariate
p Value HR (95% CI) p Value HR (95% CI)
0.915 1.12 (0.41–2.24)
ent deployment 0.031 0.36 (0.12–0.94) 0.754 0.81 (0.25–0.83)
lanted* 0.845 0.89 (0.51–3.21)
d 0.120 1.01 (0.95–2.32)
0.45 1.05 (0.22–1.09)
A during TEVAR 0.04 0.42 (0.18–1.10) 0.05 0.51 (0.31–0.88)
; HR ¼ hazard ratio; other abbreviations as in Tables 1 to 3.levels to 28 mm after 36 months, p ¼ 0.02) and a
signiﬁcant decrease in the FL diameter (from a mean
value calculated from all indicated aorta levels of 9.1
to 5 mm at 36 months; p ¼ 0.01).
However, the total maximum diameter of the
aorta in AAD was not signiﬁcantly altered at level of
the stent graft and below (from level 4 to 7) from a
mean value of 28.8 mm to 29.3 mm at 36 months
(p > 0.05), with a mean overall increase of
þ0.47 mm. However, we noted a signiﬁcant increase
in the aorta diameter above the stent graft
(from level 1 to 3) from a mean value of 31.5 mm to
35.5 mm at 36 months (p ¼ 0.05), with a mean
overall evolution of þ4.5 mm (Figure 1).
In CAD, TEVAR did not signiﬁcantly modify the
total aortic caliber (mean at all levels: from 31.8 mm
at discharge to 33.3 mm at 36 months; mean increase
of þ1.1 mm; p > 0.05), also regarding the TL and FL
either at the level of the stent graft (TL mean in-
crease of þ3 mm at 36 months [p > 0.05]; FL mean
decrease of 0.73 mm [p > 0.05]) or in the aorta
below the endograft (mean increase in the TL of
þ2.5 mm [p > 0.05]; mean decrease in the FL
of 1.5 mm [p > 0.05]).
Measurement changes of TL, FL, and total diam-
eter at different levels over time are shown in
Figures 1 to 3.
Over 36 months, the decrease in the FL corre-
sponded to greater FL thrombosis in the AAD group
than in the CAD group (AAD, 95% vs. CAD, 70%;
p < 0.01).
In AAD, FL thrombosis occurred more frequently
within the ﬁrst 18 months after the procedure
(Figure 4).
Regression analysis showed that in AAD, FL
thrombosis was directly related to freedom from MAE
and endoleaks (p ¼ 0.01) (Figure 4); however, this was
not observed for CAD (p ¼ 0.1) (Figure 5).
Type I and II endoleaks were detected in 17 of 60
patients (28%): 3 type I (17.6%) and 14 type II (82.3%).
In the AAD group, 2 type I and 6 type II endoleaks
occurred, whereas in the CAD group, there was 1 type I
endoleak and 8 type II endoleaks. Type II endoleaks
were present in 14 cases: in 3 of 14 (2.1%) cases, a type
II endoleak was evident at CTA before discharge. All
of them originated from the excluded LSA (proximal
neck <2 cm). Two endoleaks sealed spontaneously
during follow-up and were no longer apparent at 6
and 9 months CTA. In the other 12 cases, deliberate
embolization of the FL and of the origin of the ex-
cluded LSA was performed using a variety of agents.
Endoleak characteristics and embolization tech-
niques are shown in Table 6. However, after reinter-
vention, all endoleaks were successfully sealed.
TABLE 5 Univariate and Multivariate Analysis of Procedural Factors in Relation With
Endoleak and Other Outcomes (Endoleak, Mortality, and Others) in CADs
Factors
Univariate Multivariate
p Value HR (95% CI) p Value HR (95% CI)
Stent graft oversizing 0.971 1.08 (0.40–4.03)
Balloon dilation after stent deployment 0.11 0.31 (0.35–6.21)
No. of stent grafts implanted* 0.789 1.18 (0.26–4.23)
Length of aorta covered 0.581 1.37 (0.55–5.15)
Covering of the LSA 0.87 0.91 (0.47–2.88)
Embolization of LSA during TEVAR 0.39 0.57 (0.44–3.24)
*Hierarchical analysis.
Abbreviations as in Tables 1 to 4.
FIGURE 1 Aortic Remodeling Above the Stent-Graft
Whole lumen (WL) changes over time in acute aortic dissection (AAD) and chronic aortic
dissection (CAD) above the stent graft (levels 1 and 2). Interv ¼ intervention.
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187MANAGEMENT OF THE LSA. The origin of the LSA
was intentionally occluded in 14 of 29 patients (48%)
in the AAD group and in 19 of 31 patients (61%) in the
CAD group. In 11 patients (18%, 6 AADs and 5 CADs),
the origin of the occluded LSA was embolized during
the initial procedure, immediately after stent graft
deployment to avoid FL revascularization. In 6 pa-
tients (4 AADs and 2 CADs), in whom the LSA was
excluded only by the stent graft (without direct
embolization), a type II endoleak developed. A sec-
ondary intervention was performed, via a left brachial
approach, to exclude the LSA origin, and complete
sealing of the leak was successfully achieved in all of
them. As the univariate analysis showed, LSA
coverage had no bearing on the development of type
II endoleaks, in either AAD or CAD (p > 0.05); instead
embolization of the LSA was observed to confer some
protection against endoleak development in AAD
(p ¼ 0.04), but not in CAD (p ¼ 0.39). Moreover,
embolization of the LSA had a direct inﬂuence on
improvement of FL thrombosis and a reduction in
endoleak development but not MAE (p ¼ 0.05)
(Table 4). On multivariate analysis, either covering or
embolization of the LSA in CAD did not demonstrate
an association with other outcomes such as improved
aortic remodeling, mortality, and other MAE. Post-
operative carotid-subclavian surgical bypass was
needed in only 2 patients with AAD (2 of 14, 14.2%)
who experienced neurological symptoms. No spinal
cord ischemia associated with intentional coverage of
the LSA has been observed.
POST-DILATION. Dilation of the stent graft was per-
formed to obtain a better seal to the aortic wall at the
level of the proximal and distal landing zones.
Moreover, it was also performed when multiple de-
vices were inserted at the level of the overlapping
segments in 18 patients (62%) in the AAD group and in
18 patients (58%) in the CAD group.
In both groups, the rate of endoleaks was not
signiﬁcantly different between patients who under-
went stent graft dilation and those who did not. In
fact, in patients with AAD, 8 endoleaks occurred;
endoleaks occurred in 3 of 18 patients who underwent
post-dilation and in 5 of 11 in patients who did not
(p ¼ 0.09). In CAD, 9 endoleaks occurred: 4 in patients
with post-dilation and 5 in patients without (p ¼ 0.9).
In AAD over 36 months, FL thrombosis rates were
higher in patients who had undergone stent graft
dilation compared with those patients who did not (17
of 18 vs. 7 of 11; p < 0.05). On univariate and multi-
variate analyses, post-stent deployment dilation was
correlated only with improved FL thrombosis (uni-
variate analysis, p ¼ 0.031) but not with a greaterhigher freedom from MAE or endoleaks (Table 3)
(multivariate analysis, p ¼ 0.754).
In the CAD group, the FL thrombosis rate, observed
at 36 months of follow-up, was constant over that
period but was not directly related to freedom from
MAE or endoleaks (Figure 5). Moreover, multivariate
analysis showed different results for patients who
underwent stent graft dilation and those who did not
(Table 4).
However, the 2 cases of antegrade dissections were
not associated with dilation of the stent graft as the
complication, which, in both cases, occurred imme-
diately after stent graft deployment.
DISCUSSION
Several articles have outlined that the rationale of
endovascular treatment for type B dissections relies
on the exclusion of the primary entry tear inducing
FIGURE 2 Aortic Remodeling at the Level of the Stent-Graft
True lumen (TL) and false lumen (FL) changes over time in acute aortic dissection and
chronic aortic dissection at the level of the stent graft (levels 3 to 5). Abbreviations as in
Figure 1.
FIGURE 3 Aortic R
TL and FL changes o
Abbreviations as in F
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188aortic remodeling and avoiding major complications
either in an acute or chronic condition (1–5,7).
As reported, aortic remodeling consists of FL
thrombosis with progressive reduction of its diameter
and concomitant progressive enlargement of the TL
(5,8–11).
However, in chronic dissections, some reports
indicate that endovascular repair should not signiﬁ-
cantly alter the aortic morphology (10). This behavior
reﬂects the lower FL thrombosis rate that we observed
in CAD compared with AAD (Figures 1 to 5).emodeling Below the Stent-Graft
ver time in AAD and CAD below the stent graft (levels 6 and 7).
igures 1 and 2.In our study, FL thrombosis was more evident in
AAD within the ﬁrst 18 months after treatment. These
outcomes are similar to the results of other recent
studies that stress the higher capacity of remodeling
of acute rather than chronic dissection after TEVAR
(5,9,11,12).
Our results conﬁrmed that in AAD, FL thrombosis
and shrinkage is directly proportional to the absence
of MAE and endoleaks (Figure 4). By comparison, FL
thrombosis in CAD is less prominent initially and at
the same time has a weak correlation with MAE and
endoleak occurrence. This ﬁnding is probably related
to the fact that in our cohort mainly type II endoleaks
from the LSA occurred (Figure 5). Apart from FL and
TL changes in size, which are well known, the entire
lumen of the aorta above the stent graft has not yet
been analyzed (13,14). Our results showed that the
whole aortic lumen tends to increase signiﬁcantly
above the stent graft (þ4.5 mm in 36 months) in AAD,
but not in CAD. This may be related to the increased
active remodeling of the aortic wall that is typical of
AAD and also associated with increased shear stress
forces above the stent graft, which may lead to
aneurysm formation or retrograde type A dissection.
We also analyzed some procedural factors that may
affect the fate of the aorta after stent graft deploy-
ment. As far we are aware, these procedural factors in
relation to aortic remodeling have not previously
been clearly examined.
For example, stent graft oversizing is still conten-
tious (15–18). Multiple factors must be evaluated,
especially with regard to the patient’s age and nature
of the aortic disease (e.g., acute dissection, chronic
dissection, trauma).
Stent graft oversizing has been recommended to be
minimal (#20%), using the nondissected midaortic
arch as the reference vessel diameter, in those pa-
tients with a history of trauma (2,15,16). In fact,
greater oversizing may be associated with endograft
collapse (infolding) and consequent incomplete seal-
ing (17,18). Moreover, in the case of AAD, a decrease
in the degree of stent graft oversizing potentially re-
duces the barotrauma on the fragile aortic wall,
reducing the risk of antegrade dissection or aortic
rupture. In 1 study, stent graft oversizing $20% was a
signiﬁcant predictive factor for reintervention (19).
In our experience, the degree of stent graft over-
sizing was observed to be slightly higher in CAD
(15.5%) than in AAD (13.8%) (p ¼ 0.07). What we
observed is that stent graft oversizing has a bearing
on either endoleak or MAE in either AADs or CADs
(Tables 3 and 4).
There is a paucity of literature regarding out-
comes and long-term morphological changes in
FIGURE 4 Clinical Outcomes and False Lumen Thrombosis in AAD
Kaplan-Meier curves showing the direct relationship between freedom from major adverse events (MAEs)/endoleaks and FL thrombosis over
the time in AAD (p ¼ 0.01). Abbreviations as in Figures 1 and 2.
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189both AAD and CAD in relation to stent graft dilation
(5,8–18,20).
In our study, we investigated the relationship be-
tween stent graft dilation, clinical outcomes, inci-
dence of complications, and aortic remodeling in both
AAD and CAD. In AADs, at both 18 and 36 months,FIGURE 5 Clinical Outcomes and False Lumen Thrombosis in CAD
Kaplan-Meier curves showing nonsigniﬁcant relationship between freedo
Abbreviations as in Figures 1, 2, and 4.higher FL thrombosis rates were observed in those
patients in whom dilation was performed. From these
results, we might suggest that stent graft dilation
improves FL thrombosis, especially in AAD (95%
AAD vs. 70% CAD of patients with complete FL
thrombosis; p < 0.01). Hence, improved FLm of MAEs/endoleaks and FL thrombosis over time in CAD (p ¼ 0.1).
TABLE 6 Description and Treatment of the Endoleaks
Patient #
Type of
Endoleak Dissection Origin Treatment
Follow-up
(Months)
1 II AAD LSA Embolization with coils and Onyx 62
2 II AAD LSA Embolization with coils and Onyx 36
3 II AAD LSA Embolization with coils 38
4 I AAD Distal (low ﬂow) Embolization with coils and Onyx 41
5 II AAD LSA Embolization with coils and Onyx 39
6 II AAD LSA Embolization with coils 36
7 I AAD Distal (low ﬂow) None 36
8 II CAD LSA Embolization with coils 39
9 II AAD LSA None 36
10 II CAD LSA None 51
11 II CAD LSA Embolization with Onyx 39
12 II CAD LSA Embolization with coils 37
13 I CAD Distal (low ﬂow) None 49
14 II CAD LSA Embolization with coils and Onyx 36
15 II CAD LSA Embolization with coils and Onyx 52
16 II CAD LSA Embolization with Onyx 36
17 II CAD LSA Embolization with coils and Onyx 38
Abbreviations as in Tables 1 and 3.
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190thrombosis has been related to improved freedom
from endoleak and MAE in AAD (Figure 4). On the
contrary, in the CAD group, there was no signiﬁcant
difference in the FL thrombosis rate between patients
who underwent stent graft dilation and those who did
not (72% dilation vs. 68% no dilation p > 0.05).
To explain these differences, one might consider
the greater stiffness of the aorta in chronic dissec-
tions that prevents stent graft dilation from inﬂu-
encing the aortic remodeling. This concept can be
also considered when we evaluate the number of
stent grafts implanted. In CAD patients, more stent
grafts (n ¼ 57) were implanted than in AAD patients
(n ¼ 43) (p ¼ 0.048).
All CAD patients were successfully treated by
covering a signiﬁcantly longer segment of the aorta
than in AAD patients (Table 2). This may indicate the
need to extend the stent grafts more distally to obtain
complete exclusion of the FL and to increase the TL
diameter. By comparison, in AAD, shorter distances
can be covered given the high clinical success rate
and remodeling and the higher risk of paraplegia
(Table 2, Figure 4). We observed that stent graft
extension was required in 2 AAD patients to treat
malperfusion syndrome: from this small experience,
we could presume that in some cases, a single module
could not be enough, even though this is not statis-
tically signiﬁcant in either AAD or CAD (Tables 3
and 4). Regarding endoleaks, Sze et al. (6) investi-
gated factors portending endoleaks after TEVAR.
Signiﬁcant factors found were coverage of the LSA, asmall radius of aortic arch curvature, and incomplete
proximal apposition of the stent graft. However,
those factors were signiﬁcantly associated with
complex endoleaks (combination of types Ia and II)
but not with pure type II endoleaks, which are mainly
present in our population. With regard to coverage of
the LSA, intentional exclusion of the LSA without
surgical revascularization had been described as a
feasible technique (9,21–23). However, according to
the results of both our study and that of Sze et al. (6),
coverage of the LSA does not seem to be strongly
correlated with a different incidence of pure type II
endoleaks compared with patients without coverage
of the LSA. Furthermore, in our study, we analyzed
the effect of embolization of the covered LSA, and
this has been signiﬁcantly inversely related to the
development of an endoleak; because this technique
signiﬁcantly reduces endoleak development, it has
also been correlated with improved FL thrombosis
(p ¼ 0.05) (Table 4, Figure 4).
Hence, embolization of the LSA origin might be
performed during the initial procedure. Noncritical
arm ischemia was reported in several studies
(9,22,23). A complete evaluation of the blood ﬂow at
the level of the vertebral and mammary arteries is
mandatory to avoid neurological complications. The
other factors, i.e., aortic arch radius and incomplete
apposition of the stent graft, have not been consid-
ered in our study because in our case series, we did
not ﬁnd signiﬁcant variability in aortic arch radius
and proximal apposition of the different stent grafts.
STUDY LIMITATIONS. This is a retrospective obser-
vational study with a relatively small number of pa-
tients and relatively small number of MAEs and
endoleaks. In addition, a wide range of different
types of stent grafts were used.CONCLUSIONS
Aortic remodeling after TEVAR can be associated with
the characteristics of the dissection and the proce-
dural technique. In particular, TEVAR of AAD results
in a greater degree of aortic remodeling than in CAD.
According to the type of aortic dissection, different
techniques such as post-dilation, embolization of the
LSA, and distal extension of the stent graft may be
considered.
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PERSPECTIVES
WHAT IS KNOWN? Beside certain evidence that AADs
show a higher degree of remodeling compared with CADs,
procedural factors that may affect further clinical out-
comes have not been fully explored.
WHAT IS NEW? Aorta remodeling after TEVAR can be
related to the characteristics of the dissection and to the
procedural technique. Acute dissections seem to be more
sensitive than chronic.
WHAT IS NEXT? The most appropriate endovascular
techniques may be selected according to the type of
aortic dissection.
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